About Parry Pharma Private Limited
Data last updated:
Parry Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 November 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ1992PTC018540. Its GSTIN is 24AABCP1373R1Z3 (Gujarat).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Nitin Shantilal Bhagat and Neha Vinish Sheth.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shed No. 402/C Phase – II G.I.D.C. Vatva, Ahmedabad, Gujarat, India – 382445.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.83 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹5.31 Lakh (net margin 1.9%) and EBITDA of ₹16.56 Lakh (EBITDA margin 5.9%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 8% over five years.
The company has about 4 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.57 Cr on record. Court records list 4 cases involving the company, including 2 filed by the company and 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website parry-pharma.com.
Company details
Contact details
Parry Pharma Private Limited's registered office is in Ahmedabad, Gujarat. Its website is parry-pharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressShed No. 402/C Phase – II G.I.D.C. Vatva, Ahmedabad, Gujarat, India – 382445
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Parry Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Parry Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Parry Pharma Private Limited, buy the company report.
Financials of Parry Pharma Private Limited
FY 2025 filings availableParry Pharma Private Limited reported revenue of ₹2.83 Cr (up 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 23% growth in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16.56 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.31 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.9% | ||||
| Net Profit Margin | 1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Parry Pharma Private Limited, buy the company report.
Board of directors of Parry Pharma Private Limited
Parry Pharma has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nitin Shantilal Bhagat Also directs: Artus Pharma Private Limited | Director | 06 Nov 1992 | 33 Years 11 Months | Current |
| Neha Vinish Sheth | Director | 05 Aug 2024 | 2 Years 2 Months | Current |
| Nupur Nitinbhai Bhagat | Director | 05 Aug 2024 | 2 Years 2 Months | Current |
Peer comparison
Parry Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vitor Pharma Private Limited | ₹2.86 Cr (FY 2022) | -21.0% | Mumbai, Maharashtra, India | |||
| Doctor Medisciences (India) Private Limited | ₹2.84 Cr (FY 2025) | 23.0% | Mumbai, Maharashtra, India | |||
| Parry Pharma Private Limitedthis company | ₹2.83 Cr (FY 2025) | ₹5.31 Lakh | 1.9% | 23.0% | 4 | Ahmedabad, Gujarat, India |
| Sabhika Pharmaceuticals Private Limited | ₹2.83 Cr (FY 2025) | 218.0% | Bangalore, Karnataka, India | |||
| Bhavyas Pharmaceuticals Private Limited | ₹2.83 Cr (FY 2025) | -11.0% | Medak, Telangana, India | |||
| Synaptics Pharmaceuticals Private Limited | ₹2.82 Cr (FY 2024) | -36.0% | Hyderabad, Telangana, India | |||
| Ayurprakash Herbal Private Limited | ₹2.82 Cr (FY 2025) | 12.0% | New Delhi, Delhi, India |
To see the full peer comparison of Parry Pharma Private Limited, buy the company report.
Auditor
Parry Pharma Private Limited is audited by J. A. BHATT & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J. A. BHATT & CO. | FY 2024 | 101331W |
Shareholding
The shareholding of Parry Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Parry Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Oct 2024 | 100998291 | Hdfc Bank Limited | ₹7 Lakh | Open | |
| 24 Sep 2024 | 100979023 | Others | ₹1.5 Cr | Open |
Total charge records: 2 View all charges
Legal cases
Parry Pharma Private Limited has 4 court cases on record: 2 filed by Parry Pharma, 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 1 | 0 |
| High courts | 2 | 1 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, GUJARAT | Appeal | Filed by the company against State of Gujarat Through B R Choksi | Disposed |
| High Court, GUJARAT | Court case (SCR.A) | Filed against the company by State of Gujarat, Thro' B. R. Choksi, Sr. Drugs Inspector | Disposed |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed by the company against Mayurbhai Shah Pro. of Jay Ambe Pharma | Disposed |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by an individual | Disposed |
To see the full case history of Parry Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Parry Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Parry Pharma Private Limited has a workforce of 4 employees on its EPFO records as of Mar 11, 2025, across 1 active EPFO establishment.
GST
Parry Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AABCP1373R1Z3 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Parry Pharma Private Limited, buy the company report.
Recent activity
Parry Pharma Private Limited has 6 board changes on record since 1992: 3 appointments and 3 cessations. The latest: Neha Vinish Sheth ceased to be Additional Director on 29 Sep 2024.
Frequently asked questions
Parry Pharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 November 1992 (34+ years old) and is registered under CIN U24231GJ1992PTC018540.
Parry Pharma has 3 current directors:
- Nitin Shantilal Bhagat - Director
- Neha Vinish Sheth - Director
- Nupur Nitinbhai Bhagat - Director
The latest financial statements of Parry Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Parry Pharma is 24AABCP1373R1Z3, registered in Gujarat.
The CIN (Corporate Identification Number) of Parry Pharma is U24231GJ1992PTC018540. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Parry Pharma has 4 court cases on record: 2 filed by the company and 2 filed against it. Most are in the district courts.
Parry Pharma was incorporated on 06 November 1992, making it 34+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Parry Pharma by revenue are Vitor Pharma Private Limited, Doctor Medisciences (India) Private Limited, Sabhika Pharmaceuticals Private Limited, Bhavyas Pharmaceuticals Private Limited, Synaptics Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Neha Vinish Sheth ceased to be Additional Director on 29 Sep 2024. Nupur Nitinbhai Bhagat ceased to be Additional Director on 29 Sep 2024. Vikas Thakorbhai Gandhi ceased to be Director on 07 Aug 2024. Parry Pharma has 6 board changes on record in total.
Parry Pharma can be reached through the website parry-pharma.com. Its registered office is in Ahmedabad, Gujarat, India.
The registered office of Parry Pharma is at Shed No. 402C Phase – II G.I.D.C. Vatva, Ahmedabad, Gujarat, India – 382445.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
